173 related articles for article (PubMed ID: 23420118)
1. Information for adequate prescribing to older patients : an evaluation of the product information of 53 recently approved medicines.
Beers E; Egberts TC; Leufkens HG; Jansen PA
Drugs Aging; 2013 Apr; 30(4):255-62. PubMed ID: 23420118
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Information in Summaries of Product Characteristics (SmPCs) on the Use of a Medicine in Patients With Hepatic Impairment.
Weersink RA; Timmermans L; Monster-Simons MH; Mol PGM; Metselaar HJ; Borgsteede SD; Taxis K
Front Pharmacol; 2019; 10():1031. PubMed ID: 31607904
[No Abstract] [Full Text] [Related]
3. Effect of safety issues with HIV drugs on the approval process of other drugs in the same class: an analysis of European Public Assessment Reports.
Arnardottir AH; Haaijer-Ruskamp FM; Straus SM; de Graeff PA; Mol PG
Drug Saf; 2011 Nov; 34(11):1101-14. PubMed ID: 21981437
[TBL] [Abstract][Full Text] [Related]
4. Ethnicity-Specific Drug Safety Data in European Medicines Agency Registration Dossiers, European Public Assessment Reports, and European and Singapore Drug Labels: Lost in Translation?
Maliepaard M; Taams AC; Sung C; Poh J; Yu Y
Pharmaceut Med; 2019 Oct; 33(5):407-416. PubMed ID: 31933229
[TBL] [Abstract][Full Text] [Related]
5. Medicinal products for geriatric patients in Germany : Current status of regulatory requirements and clinical reality.
Gempel-Drey G; Drey M
Z Gerontol Geriatr; 2020 Jul; 53(4):327-333. PubMed ID: 31041579
[TBL] [Abstract][Full Text] [Related]
6. The views of healthcare professionals, drug developers and regulators on information about older people needed for rational drug prescription.
Beers E; Egberts TC; Leufkens HG; Jansen PA
PLoS One; 2013; 8(8):e72060. PubMed ID: 23977208
[TBL] [Abstract][Full Text] [Related]
7. Natural language processing-based assessment of consistency in summaries of product characteristics of generic antimicrobials.
Shimazawa R; Kano Y; Ikeda M
Pharmacol Res Perspect; 2018 Dec; 6(6):e00435. PubMed ID: 30455958
[TBL] [Abstract][Full Text] [Related]
8. Clinical relevance of information in the Summaries of Product Characteristics for dose adjustment in renal impairment.
Salgado TM; Arguello B; Martinez-Martinez F; Benrimoj SI; Fernandez-Llimos F
Eur J Clin Pharmacol; 2013 Nov; 69(11):1973-9. PubMed ID: 23884582
[TBL] [Abstract][Full Text] [Related]
9. The Quality and Reliability of Information in the Summaries of Product Characteristics.
Drelich E; Religioni U; Chung K; Kaźmierczak J; Blicharska E; Neumann-Podczaska A; Krysiński J; Merks P
Int J Environ Res Public Health; 2022 Feb; 19(4):. PubMed ID: 35206371
[TBL] [Abstract][Full Text] [Related]
10. Biomarker and Companion Diagnostics-A Review of Medicinal Products Approved by the European Medicines Agency.
Orellana García LP; Ehmann F; Hines PA; Ritzhaupt A; Brand A
Front Med (Lausanne); 2021; 8():753187. PubMed ID: 34790681
[No Abstract] [Full Text] [Related]
11. Harmonization of summaries of product characteristics (SmPCs) of drugs with the same active ingredients: an evaluation of SmPCs of the most frequently prescribed active substances.
Gahr M; Connemann BJ; Muche R; Zeiss R; Wolf A
Eur J Clin Pharmacol; 2022 Mar; 78(3):419-434. PubMed ID: 34705065
[TBL] [Abstract][Full Text] [Related]
12. Representation of older patients in the safety analysis of protein kinase inhibitor registration studies.
van Kampen E; van Bussel MTJ; Oude Munnink TH; Touw DJ; Broekman KE
J Geriatr Oncol; 2023 Nov; 14(8):101636. PubMed ID: 37806290
[TBL] [Abstract][Full Text] [Related]
13. Reported hepatotoxicity and hepatotoxicity guidance in the product information of protein kinase inhibitors in oncology registered at the European Medicines Agency.
Maliepaard M; Faber YS; van Bussel MTJ
Pharmacol Res Perspect; 2023 Apr; 11(2):e01067. PubMed ID: 36846954
[TBL] [Abstract][Full Text] [Related]
14. Assessing the information in the Summaries of Product Characteristics for the use of medicines in pregnancy and lactation.
Arguello B; Salgado TM; Fernandez-Llimos F
Br J Clin Pharmacol; 2015 Mar; 79(3):537-44. PubMed ID: 25224071
[TBL] [Abstract][Full Text] [Related]
15. The evidence base for psychotropic drugs approved by the European Medicines Agency: a meta-assessment of all European Public Assessment Reports.
Erhel F; Scanff A; Naudet F
Epidemiol Psychiatr Sci; 2020 Apr; 29():e120. PubMed ID: 32336312
[TBL] [Abstract][Full Text] [Related]
16. What should patients do if they miss a dose? A systematic review of patient information leaflets and summaries of product characteristics.
Albassam A; Hughes DA
Eur J Clin Pharmacol; 2021 Feb; 77(2):251-260. PubMed ID: 32989529
[TBL] [Abstract][Full Text] [Related]
17. [Use of summaries of product characteristics (SmPC) among family doctors and pharmacists in the context of the aut-idem regulation: Results of an exploratory cross-sectional survey].
Gahr M; Freudenmann RW; Connemann BJ; Schönfeldt-Lecuona C; Muche R; Hiemke C; Sillmann YM
Z Evid Fortbild Qual Gesundhwes; 2020 Apr; 150-152():45-53. PubMed ID: 32444219
[TBL] [Abstract][Full Text] [Related]
18. Results on patient-reported outcomes are underreported in summaries of product characteristics for new drugs.
Haag S; Junge L; Lotz F; McGauran N; Paulides M; Potthast R; Kaiser T
J Patient Rep Outcomes; 2021 Dec; 5(1):127. PubMed ID: 34874524
[TBL] [Abstract][Full Text] [Related]
19. Inconsistencies of absolute drug-drug contraindication reports: Analysis of Summaries of Product Characteristics of commonly prescribed drugs.
Weisbach L; Schuster AK; Hartmann M; Dürr P; Then MI; Andrikyan W; Fromm MF; Maas R; Farker K
Br J Clin Pharmacol; 2023 Aug; 89(8):2552-2560. PubMed ID: 37002812
[TBL] [Abstract][Full Text] [Related]
20. Information on new drugs at market entry: retrospective analysis of health technology assessment reports versus regulatory reports, journal publications, and registry reports.
Köhler M; Haag S; Biester K; Brockhaus AC; McGauran N; Grouven U; Kölsch H; Seay U; Hörn H; Moritz G; Staeck K; Wieseler B
BMJ; 2015 Feb; 350():h796. PubMed ID: 25722024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
